Non-Traditional Antibacterial Therapeutic: Focus on Safety, Manufacturing, and Regulatory Dynamics
- 19 November 2024
- book chapter
- Published by Springer Nature
- p. 787-810
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Chitosan film of thiolated TPGS-modified Au-Ag nanoparticles for combating multidrug-resistant bacteriaColloids and Surfaces A: Physicochemical and Engineering Aspects, 2024
- Antimicrobial peptides for combating drug-resistant bacterial infectionsDrug Resistance Updates, 2023
- Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality managementMetabolomics, 2022
- Antibiotic resistance: The challenges and some emerging strategies for tackling a global menaceJournal of Clinical Laboratory Analysis, 2022
- Recent advances in bacteriophage-based therapeutics: Insight into the post-antibiotic eraActa Pharmaceutica Sinica B, 2022
- Real-world evidence and product development: Opportunities, challenges and risk mitigationWiener klinische Wochenschrift, 2021
- Principles and Applications of Fermentation Technology2018
- Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?Applied Microbiology and Biotechnology, 2018
- The Threat of Antimicrobial Resistance on the Human MicrobiomeMicrobial Ecology, 2017
- Microbiome therapeutics — Advances and challengesAdvanced Drug Delivery Reviews, 2016